Ayurveda Project

PROJECT REPORT ON

TO ASSESS THE USAGE OF ALLOPATHIC AND AYURVEDIC PRODUCTS BY

DIFFERENT DOCTORS(THE VEIWS OF DOCTORS)

SUBMITTED TO: SUBMITTED BY:

Mr. J.S.SAINI LOVEKESH SARDA SENIOR MANAGER MARKETING REGD.NO:10806768 IndSwift.ltd LOVELY PROFESSIONAL UNIVERSITY

TABLE OF CONTENTS

ACKNOWLEDGEMENT

PREFACE

EXECUTIVE SUMMARY

CHAPTER 1.

Introduction to study

Review of literature

CHAPTER 2

Company profile

CHAPTER 3 Objectives of the study

Research methodology

Research design

Sample design and size

Sources of data

Scope of the study

CHAPTER 4

Data analysis

CHAPTER 5

Findings

Recommendations

Conclusion

Questionnaire

Bibliography

PREFACE

Our Institute has made a sincere effort in providing linkage between industry and students.

Industrial Training is a platform for a student to supplement his theoretical knowledge with

practical knowledge. The main purpose of Industrial Training is to get an exposure in industrial

environment, which is not possible in classroom.

The training also tells about the limitation of the knowledge of a person and helps in clearing the

concept easily and effectively. The Industrial training also made me aware of the importance of

discipline, punctuality, teamwork, sense of responsibility .

I undertook my project at IndSwift. Ltd.

It is a pioneer organization in manufacturing and supplying allopathic and ayurvedic drugs in

India and to other countries. The training is definitely going to play an important role in

developing an aptitude for handwork and self confidence for my successful future.

ACKNOWLEDGMENT

I am thankful to Mr. S.R.MEHTA who is chairman of the company for permitting me to

complete the project in such a reputed company in the market. I would like to thank

Mr. J.S. SAINI the project guide of industry who guide me how to work on project report.

Helped me to choose the project topic and provide information time to time. I express an extreme

sense of gratitude to Dr. JASDEEP DHAMI for their suggestions to me when I am needed.

I wish to thanks the entire staff & workers of IndSwift. LTD for their suggestions, guidance &

co-operation.

EXECUTIVE SUMMARY

PROJECT TITLE: EVALUATION STUDY TO ASSESS THE USAGE OF ALLOPATHIC AND

AYURVEDIC PRODUCTS IN VEIWS OF DOCTORS.

My project is to assess the usage of allopathic and ayurvedic by the doctors. In this survey I

found very zigzag results. Every doctors have different type of way to heal particulars . Some

doctors used their basic practices and some with combination therapy. This fact is totally

depending on the regions. Interior area gives you the results for combination therapy, where

developed cities provides the basic one . My project sampling was carried out in interior area of

Hamirpur (H.P). and Chandigarh . Sample size is 20 ayush doctors and 20 allopathic doctors.

Health care in Hamirpur and Chandigarh is provided by allopathic and traditional health care .

These health care services are most effective if they are compatible with the needs and aspiration

of the people . Allopathic and ayurveda services in Hamirpur and Chandigarh provided by

private, compounders and health centers of govt.

But the difference in Chandigarh and hamirpur is, in

hamirpur due to socio-cultural and economics reasons a modern health care systems not widely

prevalent. So they more depends on traditional systems of medicines. Even in developed country

or world the use of complementary and alternative medicines has been steadily increasing in

previous decades. The basic requirement for allopathic doctors is allopathy. But ayurveda

doctors oftenly use the allopathic medicines on the customer preferences, first aid, in emergency.

As large no: of accident occurs in daily life so besides giving ayurvedic medicines to patient

these ayurveda doctors often have to take up the other modes of medication. Hence this point

accepts the allopathic treatment is life saving drug in emergency. But for long term, safe, non

toxic is herbal . This whole treatment is based on the diseases. When a patient is diagnosed with

the medical problem, the allopathic doctors in audience with cunsultant of traditional therapy

decides on the treatment procedure. If the ailment is critical, the patient is sent to the allopathic

doctors . For instance, if a person is suffering from asthma or bronchial pain or diabetes and is in

early stages of diseases, allopathic medicines along with ayurveda can be suggested. In the way,

modern medicines works to reach the disease while traditional one cure and cleanse the body.

To comparison both system is impossible. But market

survey has still weightage of allopathic. But ayurveda is on ignition stage.

OBJECTIVE OF THE STUDY:

1> To assess the usage of allopathic or ayurveda system by the doctors.

2> To study the preferences of the systems by the doctors taking the reasons

as side effects, time duration, safety.

3> To study the availability the medicines in clinic or nearby retailers.

4> To know diversifying allopathic to ayurveda by industries is right step or

not.

5> To study the order of preferences by the doctors towards the different

medical professionals.

SCOPE OF THE STUDY:

The scope of study means the subject matter to be researched in the study . It

defines the overall rationale of the study by explaining the geographically area of the study along

with type of the data. In order to accomplish the objectives of the project . Survey conducted in

Himachal Pradesh and Chandigarh to fill the questionnaire by the doctors which designed for

the purpose of the survey . On the basis of data collected I analysis the result of the project .

RESEARCH METHODOLOGY

In order to gets information by various reasons the research methodology is as follows:

DATA COLLECTION:

Adequate and authentic data is the foundation stone for an analysis. It is very necessary that the

data should be adequate and relevant so that the analysis which we derive from that data is exact.

So data collection requires due attention and care. In order to get the required basic information

about the usage of medical system by doctors and for what disease . I relied on both primary data

and secondary data.

PRIMARY DATA:

Regular visit to the organization i.e.IndSwift Ltd. In Chandigarh and after regular visit to market

and meetings with doctors was made to obtain the required information and learn about the

market and organisation how it works. Interviews with the management officials and staff of the

organization to get latest information.

SECONDARY DATA:

Books, Magazines, Articles from internet etc. constitute the secondary sources of information for

the project report.

SAMPLING PLAN:

Universe : The population of study consists of doctors and retailers (pharmacy shops) I

hamirpur and chandigarh.

Sample Size : Sample Sizes 40 respondants. 20 doctors of ayurveda and 20 from allopathic .

Sampling Technique : I have used technique of convenience sampling.

Geographical scope: Hamirpur (h.p) and Chandigarh . .

Tool for data analysis : Percentage method for getting results.

FINDINGS:

In my market survey I found weightage towards the allopathic products . 35% of allopathy

doctors use ayurveda medicine in prescription but in case of ayurvedic doctors 80% of them ,

they are using allopathic medicine in prescription. I also find that the combination therapy made

by doctors doing great job in healing the disease like coronary heart disease , cancer and many

more chronicle diseases. As allopathic is first preference by the doctors but ayurveda is

upcoming one.

RECOMMENDATION:

According to findings that in current scenario doctors and patient move towards the

ayurveda but allopathic still rules. I would like to recommend IndSwift

1. Doctors have yet to find a solution for conditions like cancer pain and chronic

pancreatitis in complementary therapies where modern interventional pain procedures

are very effective. So herbal drugs use in cancer and heart disease is going to be

popular for the doctors. This finding helps IndSwift to capture market by

manufacturing of anti cancer herbal drug.

2. My findings helps IndSwift that it should work on herbal medicines but along with

allopathic.

3. In future company get benefit if they prepare combination therapy medicines with no

side effect and try to be 100% cure guarantee.

CHAPTER- 1

INTRODUCTION TO SUBJECT:

AYURVEDA

Ayurveda (Devanāgarī: आयु�र्वे�द, the 'science of life') is a system of

traditional medicine native to India, and practiced in other parts of

the world as a form of alternative medicine. In Sanskrit, the word

Ayurveda comprises the words āyus, meaning 'life' and veda

meaning knowledge . Evolving throughout its history, Ayurveda remains an influential system of

medicine in South Asia. The earliest literature of Ayurveda appeared during the Vedic period in

India. The Sushruta Samhita and the Charaka Samhita were influential works on traditional

medicine during this era. Ayurvedic practitioners also claim to have identified a number of

medicinal preparations and surgical procedures for curing various ailments and diseases.

As per Indian heritage and science "Ayurveda" is a Upa Veda or anexture of four main

vedas(Knowledge Systems). the famous treaties of Ayurveda, "Charaka Samhita" by sage

"Charakan", details the prevention and treatment of disease and "Sushruta Samhita" of Sage

"Sushruta" deals Ayurvedic Surgical procedures. In Ayurvedic system, Prevention of all types of

disease have prominent place than treatment, including restructuring of life style to align with the

course of nature and four seasons, which will guarantee complete wellness.

Ayurveda is considered to be a form of complementary and alternative medicine (CAM) within

the western world, where several of its methods—such as herbs, massage, and Yoga as exercise

or alternative medicine—are applied on their own as a form of CAM treatment.

Ayurveda believes in five great Elements (Devanāgarī: पं�चतत्र्वे ; earth, water, fire, air and space)--

to compose the Universe, including the human body.Chyle, blood, flesh, fat, bone, marrow, and

semen are believed to be the seven primary constituent elements (Devanāgarī: सप्तधा�त�) of the

body.Ayurveda stresses a balance of three substances: wind/spirit/air, phlegm, and bile, each

representing divine forces. According to Ayurveda, these three regulatory principles--Doshas

(Devanāgarī: त्रि�द�श्�)—vata (wind/spirit/air), pitta (bile) and kapha (phlegm)—are important.

Traditional beliefs hold that humans possess a unique constellation of Doshas. In Ayurveda, the

human body perceives attributes of experiences as 20 Guna (Devanāgarī: गु�न, meaning

qualities).Surgery and surgical instruments are employed. It is believed that building a healthy

metabolic system, attaining good digestion, and proper excretion leads to vitality. Ayurveda also

focuses on exercise, yoga, meditation, and massage.Thus, body, mind, and spirit/consciousness

need to be addressed both individually and in unison for health to ensue.

The concept of Panchakarma (Devanāgarī: पं�चकर्म� ) is believed to eliminate toxic elements from

the body. Eight disciplines of Ayurveda treatment, called Ashtanga (Devanāgarī: अष्टां��गु), are

given below:

Surgery (Shalya-chikitsa).

Treatment of diseases above the clavicle (Salakyam).

Internal medicine (Kaaya-chikitsa).

Demonic possession (Bhuta vidya): Ayurveda believes in demonic intervention and—as a

form of traditional medicine—identifies a number of ways to counter the supposed effect of

these interferences.[13] Bhuta vidya has been called psychiatry.

Pediatrics (Kaumarabhrtyam).

Toxicology (Agadatantram).

Prevention and building immunity (rasayanam).

Aphrodisiacs (Vajikaranam).

Ayurveda gained recognition in the Western world as

medical scholars, notably , Frank John Ninivaggi MD of Yale University School of Medicine,

researched and outlined its various postulates in one major textbook form suitable to Western

academic science. In the United States of America, the NIH NCCAM expends some of its $123

million budget on Ayurvedic medicine research.

In India the government became involved in traditional drug production when the Central Drug

Research Institute patented two new drugs from ancient Ayurvedic formulas. One, a mixture of

black pepper, long pepper, and ginger, allows for the dosage of the antibiotic rifampicin to be

halved in the treatment of tuberculosis and other mycobacterial infections. The other is a

memory tonic produced from the traditional plant called brahmi. Overseas patenting of turmeric

and products of the neem tree caused controversy in India and other nations. In August the U.S.

Patent and Trademark Office canceled a U.S. patent on the wound-healing properties of turmeric

when the Indian government proved that records had existed for this use for centuries.

ALLOPATHY

Allopathic medicine and allopathy (from Greek ἄλλος, állos, other,

different + πάϑος, páthos, suffering) are terms coined by Samuel

Hahnemann, the founder of homeopathy. It meant "other than the

disease" and it was intended, among other things, to point out how traditional doctors used

methods that had nothing to do with the symptoms created with the disease, which meant that

these methods were harmful to the patients. Originally intended as a characterization of standard

medicine in the early 19th century, these terms were rejected by mainstream physicians and

quickly acquired negative overtones. During the 19th century it was used widely among irregular

doctors as a pejorative term for regular doctors.In the United States the term "allopathic" has

been used by persons not related to homeopathy, but it has never been accepted by the medical

establishment, and is not a label that such individuals apply to themselves.

In the United States, allopathic medicine can sometimes

refer to the medical training that leads to the degree Doctor of Medicine rather than the degree

Doctor of Osteopathic Medicine, although this is uncommon. See comparison of MD and DO in

the United States.

Generally, allopathic medicine refers to "the broad

category of medical practice that is sometimes called Western medicine, biomedicine, scientific

medicine, or modern medicine", with varying degrees of acceptance by medical professionals in

different locales. In particular, the terms allopathic medicine and allopathy may be used for

regular medicine in a context of traditional medicine such as Ayurveda as well as in a context of

complementary and alternative medicine such as homeopathy (see homeopathy and allopathy).

However, many aspects of traditional medicine systems such as Ayurveda or Traditional Chinese

medicine are themselves allopathic in that they act by opposing the patient's symptoms.

SURVEY STUDY

Allopathy and ayurveda are as different as day and night, and hence the

two sets of opposing views. However, if one has to compare ayurveda and allopathy on one

platform, then such comparison might be a tad difficult. "Allopathy treats individuals as an

independent physical entity like a machine. It is further sub-divided into various organs and

systems looked after by different specialties. Whereas, ayurveda treats the individual as a whole,

considering him to be a part of the universal whole .

A positive aspect in the whole ayurveda vs allopathy

issue, is the fact that, people are now open to know more about this ancient science. Also while

there might not be prejudices or bias against the same, there are certain misconceptions, which

can only be dispelled with knowledge and information dissemination. "There are no prejudices

surrounding ayurveda. There may be misconceptions regarding its practice. If anything, the

interest in this system of medicine has been growing rapidly both in the domestic and

international market, attesting to its popularity and widespread acceptance.

My project is to assess the usage of allopathic and

ayurvedic by the doctors. In this survey I found very zigzag results. Every doctor have different

type of way to heal particulars. Some doctors used their basic practices and some with

combination therapy. This fact is totally depending on the regions. Interior area gives you the

results for combination therapy, where developed cities provides the basic one. My project

sampling was carried out in interior area of Hamirpur (h.p). and Chandigarh . Sample size is 20

ayush doctors and 20 allopathic doctors. Health care in hamirpur and Chandigarh is provided by

allopathic and traditional health care . These health care services are most effective if they are

compatible with the needs and aspiration of the people . Allopathic and ayurveda services in

Hamirpur and Chandigarh provided by private , compounders and health centers of govt.

But the difference in Chandigarh and hamirpur is, in

hamirpur due to socio-cultural and economics reasons a modern health care systems not widely

prevelant. So they more depends on traditional systems of medicines . Even in developed country

or world the use of complementary and alternative medicines has been steadily increasing in

previous decades . The basic requirement for allopathic doctors is allopathy. But ayus doctors

oftenly use the allopathic medicines on the customer preferences, first aid, in emergency. As

large no: of accident occurs in daily life so besides giving ayurvedic medicines to patient these

ayush doctors often have to take up the other modes of medication. Hence this point accepts the

allopathic treatment is life saving drug in emergency. But for long term , safe , non toxic is

herbal . This whole treatment is based on the diseases . When a patient is diagnosed with the

medical problem, the allopathic doctors in audience with consultant of traditional therapy

decides on the treatment procedure. If the ailment is critical, the patient is sent to the allopathic

doctors. For instance , if a person is suffering from asthma or bronchial pain or diabetes and is in

early stages of diseases , allopathic medicines along with ayurveda can be suggested . In the way,

modern medicines works to reach the disease while traditional one cure and cleanse the body.

To comparison both system is impossible. But market

survey has still weightage of allopathic. But ayurveda is on ignition stage.

LITERATURE AND LITERATURE REVIEW

SHANKAR.R.V(2001):

A survey of drug use patterns in western Nepal

Shankar PR, Kumar P, Theodore AM, Partha P, Shenoy N.,Dr.P.Ravi Shankar MD

Mr.A.M.Theodore MSc Department of Pharmacology Department of Community

MedicineManipal College of Medical Sciences Manipal College of Medical Sciences Pokhara,

Nepal. Pokhara, Nepal.

Dr.Pawan Kumar MD Dr. Praveen Partha DNB Department of Community Medicine

Department of Medicine Manipal College of Medical Sciences Manipal Teaching Hospital

Pokhara, Nepal. Pokhara, Nepal

Mr. Nagesh Shenoy M.Pharm Department of Community Pharmacy Manipal Teaching Hospital

Pokhara, Nepal.

Name of departments to which the work should be attributed:

Departments of Pharmacology , Community medicine AND Internal medicine Manipal College

of Medical Sciences Pokhara, Nepal.

Name and address of corresponding author:

Dr.P.Ravi Shankar , Department of Pharmacology , Manipal College of Medical Sciences

P.O.Box 155 , Deep Heights

Pokhara, Nepal.

E-mail: [email protected]

[email protected]

Abstract:

Background: In Nepal, traditional health care providers have an important role to play in the

provision of health services. Non-doctor prescribing of allopathic medicines is commonly carried

out by compounders, health assistants and other practitioners. Self-treatment in which herbal

remedies play a large role is also common. Most of the previous studies have been carried out in

the Kathmandu valley. As studies in the Pokhara valley are lacking the present study was carried

out. Methods: The study was carried out in Pokhara sub-metropolitan city and the surrounding

villages in the month of September 2001 using a semi-structured questionnaire by the health

workers of the community medicine department. The pattern of drug use in the preceding 6

month period was noted. Differences in the proportion of patients using self-medication and

complementary medicines according to age, place of residence and socioeconomic status of

family were analysed by the z test of proportions (p<0.05). Findings and conclusions: 112

households were surveyed during the study period. 120 individuals from these households had

been prescribed medications during the study period. There was a total of 164 encounters with

the health care system. Self-medication was practiced by 39 families during the study period.

Home remedies accounted for 18.9 % of the drugs used. 71.6 % of the respondents using

prescribed medications had used modern medicines. Self-medication was more common among

rural households. Improving accessibility to medicines, improvement of the government health

care system and greater integration of traditional and modern health care systems are

recommended.

Keywords: Drugs, Drug-Monitoring-methods, Non-prescription-therapeutic use, Self-medication-statistics.

Introduction:

Health care in Nepal is provided by both allopathic and traditional health care providers. Health

care services are most effective if they are compatible with the needs and aspirations of the

people. Allopathic services in Nepal can be provided by private practitioners, compounders and

the government health centres. Compounders are usually persons without a formal medical

education who have been working under a registered medical practitioner helping him prepare

medicines, dressing the patients and doing other jobs in the clinic. They usually start their own

clinics after gaining a few years experience. Traditional health care providers are classified as: a)

Faith healers: 1) Dhami-Jhankri 2) Ojha 3) Pandit-Lama-Gubhaju-Pujari and 4) Jyotishi and b)

Medical providers: 1) Baidhya-Kabiraj 2) Jadi-Buti wala.1 Dhami-jhankris are faith healers who

by beating a drum and ritualistic chanting puts the patient into a trance. Pandit, Lama, gubhaju

and pujaris are the priests of the different ethnic and religious groups of Nepal. Baidhyas and

Kabiraj are ayurvedic practitioners who use herbs along with other elixirs, metal preparations

etc. Jadibuti walas are herbalists who use only herbal preparations.

In Nepal due to historical, socio-cultural and economic reasons a modern health care system is

not widely prevalent. So there is an increased dependence on traditional systems of medicine.

Even in the developed world the use of complementary and alternative medicines (CAM) has

been steadily increasing in the previous decade.2,3 In the developed countries, patients preferring

CAM are generally female, of a high socio-economic class and with a more holistic approach to

life.4,5 In Nepal about two decades ago studies has found that the hill people turned to their

Dhami-Jhankris for much of their health care needs.6 However, these studies were mainly

concentrated around the Kathmandu valley and major political and socio-economic changes have

taken place in the past two decades. Many new medical colleges have come up all over Nepal

and the number of trained doctors has increased substantially.7 Previously it was found that most

local people preferred private dispensaries owned by so-called compounders to the free health

services at the government operated health centres.8 Unfamiliarity with the medical personnel

and absence of medicines were the reasons cited for not preferring the health centre. In Kaski

district and other selected districts of Nepal a community fund has been set up to ensure that the

health centres are well stocked with medicines.

Self-treatment of common illnesses by lay people is common in economically deprived

countries.9,10 Common reasons cited for self-medication are inaccessibility of health care

facilities, economic constraints and previous experience of illness. Since drug-use studies in the

community and factors influencing the drug use patterns are lacking in Pokhara valley the

present study was carried out.

Methods:

The study was carried out in Pokhara sub-metropolitan city, western Nepal and the surrounding

villages during the month of September 2001. The respondents were interviewed by the health

workers of the department of community medicine who were briefed before hand. A semi-

structured questionnaire was used for the interviews. The ethnic group, occupation, average

monthly family income, the number of members in the family and the address of the respondents

were noted. The pattern of drug use in the families in the six month period preceding the date of

data collection was noted. Details about the patient who had used medicines in the previous six

months, the system of medicine preferred, the practitioner and the source of medicine was also

collected. Details about the medicines, the patient outcome and the approximate expenditure on

the medicines were noted. If relevant the reason for preferring complementary and alternative

medicines(CAM) were also noted. Respondents were asked about any self-medication episodes

in their family during the preceding six months. The reason for not consulting a doctor and

details of the medicines used for self-medication was collected.

Differences in the proportion of patients using self-medication and complementary medicines

according to age, place of residence and socio-economic status of family were analysed using the

z test of proportions. A p value < 0.05 was taken as statistically significant.

Results:

One hundred and twelve respondents were interviewed using the questionnaire during the study

period. Eighty seven of the 112 households surveyed (77.7 %) were male headed. The

commonest ethnic group encountered in the study was Brahmins 34(30.3 %). Other significant

groups were Gurungs 15 (13.4 %) and Chettris 13 (11.6%). Sixty one of the total of 112

households were engaged in non agricultural pursuits.

Fifty two households were middle class by Nepalese standards with an average monthly income

between 1000 and 3000 Nepalese rupees (13 and 40 US dollars). Twenty two households were

poor with an average monthly income less than 1000 rupees (13 US dollars). Majority of the

households (66.9 %) had less than 6 members. Eighty households were urban and the rest were

rural. Seventy four households (66 %) had used prescribed medications during the study period.

One hundred and twenty individuals had been prescribed medicines during the period. Forty

three of the total of 120 individuals who had used medicines were aged between 20-30 years.

The next commonest age group was between the years 40-50.

The 120 respondents had a total of 164 encounters with the health care system in the 6 month

period preceding the study. Modern allopathic medicines were prescribed in 118 encounters. The

patients had visited more than one practitioner for an episode of illness. The doctor and the

health assistant were the commonly visited practitioners and accounted for 28 % and 27.4 % of

the total visits. Twenty eight % of the visits were to a CAM practitioner. The medical shop was

the commonest source of medicines for the respondents of the study. The medical shops sold

drugs both on prescription and also on demand from the respondents without a prescription. The

medical shops generally sold allopathic medicines along with a few CAM remedies. In the 164

encounters a total of 217 drugs were prescribed giving an average of 1.32 drugs per encounter.

Traditional medicines constituted 32.2 % of the total drugs consumed. The commonest allopathic

medicines consumed were antibiotics and paracetamol accounting for 24.3 % and 18 % of the

total drugs prescribed. The approximate family expenditure on medications during the preceding

six month period was less than 100 rupees (1.25 US dollars) in 32.9 % of the cases and more

than 250 rupees (4 US dollars) in 34 % of the cases.

Self-medication was practiced by 39 families of the 112 surveyed in the study. The commonest

drug was paracetamol accounting for 41.3 % of the drugs used. Traditional home remedies

accounted for 18.9 % of the drugs used for self-medication. The common sources of drugs used

were the medical store and herbs and roots from the surrounding forests and also obtained from

the courtyards of the houses. Among the 39 families who had taken self-medication and home

remedies in the preceding 6 month period, 24 families had spent less than 75 Nepalese rupees (1

US dollar), 12 families had spent between 75 and 225 Nepalese rupees (1 and 3 US dollars)

while 3 families had spent over 225 Nepalese rupees (3 US dollars).

A significantly greater proportion of individuals above the age of 30 years had used

complementary medicines compared to those less than or equal to 30 years of age (z=2.46,

p<0.05). CAM usage was also significantly higher among families with an average monthly

income less than 1000 rupees (13 US dollars). The commonest reasons cited for using CAM

remedies were faith in the practitioner and less side effects.

The reasons cited for the use of modern allopathic medicines from practitioners other than

doctors were non-availability or decreased accessibility of doctors or the doctor was expensive.

The reasons given for self-medication were simple illness, previous experience of treating a

similar illness and medicinal herbs were easily available in the courtyard of the house.

Discussion:

The commonest ethnic group encountered in the study were Brahmins followed by Gurungs and

Chettris. This corresponds to the data in the District development profile of Nepal.Most of the

respondents in the study were engaged in non-agricultural occupations and this could be because

80 % of the respondents were residing in Pokhara city.

A total of 217 drugs were prescribed during the 6 month period which was studied. This is

difficult to compare with previous studies as the population and socioeconomic parameters are

different. 71.6 % of the respondents using medicines had used modern medicines. In a previous

study based on the meta-analysis of literature more than 50 % of people in Nepal had used CAM

remedies. The higher use of allopathic medicines could be due to our study population being

more urban and the economic development indices of Kaski district being higher than of most

other regions in Nepal.

The respondents had visited more than one practitioner during an episode of illness. Common

reasons cited were the illness was not cured, personal attention was not given by the practitioner

and the patient did not have sufficient faith in the practitioner. The respondents preferred CAM

remedies especially for chronic illnesses which is similar to the findings in previous studies.12,13

The doctor and the health assistant were the commonly visited practitioners. Doctors in private

practice accounted for 60.2 % of the total visits to doctors. The utilisation of government health

facilities was lower than that reported by previous studies in Ethiopia and Thailand. In a previous

study in Nepal private practitioners were found to be more popular than the government health

personnel The reasons cited for the preference were the private practitioners were local people

and were more accessible at any time of the day or night. A proportion of the respondents had

visited government doctors as private patients when they were doing private practice in the

evenings.

CAM remedies continue to be popular both as home remedies and on prescription by a CAM

practitioner. Herbal remedies as shown in a previous study are easily available and in Nepal

knowledge of herbal remedies precedes that of western medicines. CAM practitioners are usually

village elders and occupy a high place in the society. Their position can be used to increase the

acceptance of modern medical practices including immunisation among the rural population.

There should be greater integration of modern and traditional medical systems which has been

achieved to large extent in the far eastern Asian countries.17 The medical shop was the

commonest source of medicines. Medical shops are common in both the urban and rural areas of

Nepal and training of the drug retailers has been tried as an approach to improving the quality of

medical care.18,19 The use of CAM remedies was significantly higher among persons above the

age of 30 years and among families of low socioeconomic status. The use was also significantly

higher among rural households. So economic criteria, lack of accessibility to modern health care

systems and easy availability of herbal remedies were the common factors predisposing to the

use of CAM remedies in Nepal.

Self-treatment and home remedies are a common and often necessary part of health care. The

reasons commonly cited for self-medication were easy availability of herbs, previous experience

of treating a similar illness and economic constraints. These were similar to the reasons cited in

previous studies.11,19 Thirty nine families surveyed had used self-medication which is similar to

reports in the literature.15,21 Analgesics were the commonest drugs used for self-medication. Self-

medication was more common among rural households (z=3.2, p<0.05) compared to urban ones.

Drug hoarding has been reported in the literature14 and distance is an important factor influencing

the utilisation of health services.8 Because of the difficulty in reaching health care services and

because the medical shops are widely distributed in the villages the rural population may be

more prone for self-medication practices.

Increased accessibility to medicines, improvement of the government health care system and a

greater integration of traditional and modern health systems will help to improve the health status

of the population. Further studies to assess drug use patterns and health care needs of the

population are urgently required.

References:

1. Gartoulla RP. Alternative medication practices (dissertation). Darjeeling( India). Centre

for Himalayan Studies, North Bengal University, 1992.

2. Nilsson M, Trehn G, Asplund K. Use of complementary and alternative medicine

remedies in Sweden. A population-based longitudinal study within the northern Sweden

MONICA project. J Int Med 2001;250(3):225-33.

3. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA et al. Long

term trends in the use of complementary and alternative medical therapies in the United

States. Ann Int Med 2001;250(3):262-8.

4. Mitzdorf U, Beck K, Horton-Hausknecht J, Weidenhammer W, Kindermann A, Takaes

M et al. Why do patients seek treatment in hospitals of complementary medicine. J Altern

Complement Med 1999;5(5):463-73.

5. Furnham A, Kirkcaldy B. The health beliefs and behaviours of orthodox and

complementary medicine clients. Br J Clin Psychol 1996;35:49-61.

6. Shrestha R, Lediard M. Faith-healers: A force for change. UNICEF, Kathmandu, 1980.

7. Sharma HB, Gautam RP, Vaidya S. (Eds.) District development profile of Nepal.

Informal sector research and study center, Kathmandu, 2001.

8. Dhungel B. Accessibility to social services in rural Nepal: a case study in Kavre district (dissertation). Bangkok. Asian institute of technology, 1983.

9. Chaulagai CN. Community financing for essential drugs in Nepal. World Health Forum 1995;16(1):92-4.

Table 1: Sources of medicine sought by the respondents during health encounters 

 Source

No. of encounters

Medical shop 61

Health post 41

Traditional practitioners 32

Home remedies 24

Hospital 6

Total 164

Table 2: Number of visits to a complementary medicine practitioner according to the age of the patients

System of medicine

Age of patient  Total

30 years >30 years

Modern 66 52 118

Complementary 16 30 46

Total 82 82 164+

z value = 2.46, p<0.05

+ The 120 persons who had been prescribed medicines in the 6 month period under evaluation had made multiple visits to the practitioners

 Table 3: Complementary medicine use according to the socioeconomic status of the family 

 Average monthly income (Rs.)

System of medicine Total

Modern Complementary

<1000 17 19 , 36

1000-3000 58 12 70

>3000 43 15 58

Total 118 46 164+

z = 2.7, p<0.05 compared to the group with average monthly income greater than 3000

z =4, p<0.05 compared to the group with average monthly income between 1000 and 3000

+ The 120 persons who had been prescribed medicines in the 6 month period under evaluation

had made multiple visits to the practitioners .

Table 4: Rural-urban differences in the frequency of self-medication

 Place of residence

Self-medication Total

Used Not used

Urban 15 58 73

Rural 24 15 39

Total 39 76 112

z value =4.55, p<0.05

REVIEW

In Nepal, traditional health care providers have an important role to play in the provision of

health services. Non-doctor prescribing of allopathic medicines is commonly carried out by

compounders, health assistants and other practitioners. Self-treatment in which herbal remedies

play a large role is also common. Most of the previous studies have been carried out in the

Kathmandu valley. As studies in the Pokhara valley are lacking the present study was carried

out. Methods: The study was carried out in Pokhara sub-metropolitan city and the surrounding

villages in the month of September 2001 using a semi-structured questionnaire by the health

workers of the community medicine department. The pattern of drug use in the preceding 6

month period was noted. The doctor and the health assistant were the commonly visited

practitioners. Doctors in private practice accounted for 60.2 % of the total visits to doctors. The

utilisation of government health facilities was lower than that reported by previous studies in

Ethiopia and Thailand. In a previous study in Nepal private practitioners were found to be more

popular than the government health personnel The reasons cited for the preference were the

private practitioners were local people and were more accessible at any time of the day or night.

A proportion of the respondents had visited government doctors as private patients when they

were doing private practice in the evenings.

CAM remedies continue to be popular both as home remedies and on prescription by a CAM

practitioner. Herbal remedies as shown in a previous study are easily available and in Nepal

knowledge of herbal remedies precedes that of western medicines. CAM practitioners are usually

village elders and occupy a high place in the society. Their position can be used to increase the

acceptance of modern medical practices including immunisation among the rural population.

There should be greater integration of modern and traditional medical systems which has been

achieved to large extent in the far eastern Asian countries. The medical shop was the commonest

source of medicines. Medical shops are common in both the urban and rural areas of Nepal and

training of the drug retailers has been tried as an approach to medical care.

2.REVIEW OF LITERATURE: ALLOPATHIC V/S AYURVEDA PRACTISES IN

TERTIARY CARE INSTITUTE URBAN NORTH INDIA.

(THIS RESEARCH PAPER IS ATTACHED ALONG WITH THIS FILE PLEASE SEE

ADOBE READER FILE )

REVIEW

This study clearly indicated the popularity of cross-pathy practises among both qualified

allopathic and ayurvedic practitioners. However, clause 1.13 of medical council of India

prohibits the allopathic practitioners from allopathic system of medicine. Hence, there is urgent

need to undertake educational and reorientation programmes of registered medical practitioner

regarding various MCI rules and regulations. Even the ayurvedic practitioners need to be

adequately trained to recognize conditions that require referrals to allopathic practitioner.

Moreover large scale epidemiology studies should be conducted both in the urban and rural part

of the country, comparing the trend of cross-pathy practises among qualified practitioner of the

both system of medicines as well as comparing the trend of CAM and allopathic drugs use as self

medication between different sections of the society . Nonetheless, high quality, clinical trails are

required to establish the safety and efficacy of ayurvedic drugs . The benefit of the patient lies in

the optimal balance and evidence based use of the two systems and this needs to be encouraged

especially in developing countries like INDIA with inadequate doctor patient ratio.

CHAPTER-2

INTRODUCTION OF COMPANY

BRIEF PROFILE OF IND SWIFT GROUP

Ind Swift Group, a legendary forename in the world Class Pharmaceutical Industry who has

broaden its horizons by plucking profound & sparkling footprints on multifarious diversified

fronts, whilst going steadily and surely, scripting a success story filled with enviable milestones

and pioneering breakthroughs and has subsequently emergent as a group with an annual turn

over of 1600 Crore.

ORGANISATIONAL STRUCTURE-IND SWIFT GROUP

Ind Swift group, as pharmaceutical business model is one of India's largest manufacturer of high

growth multi segment pharmaceutical finished dosage forms and API's (Active Pharmaceutical

Ingredients).

Manufacturing of Pharmaceutical finished dosage are carried out at 7 state-of-the art

manufacturing facilities which are second to the none are duly certified and approved by WHO

GMP, spread over an area of 12, 00, 000 sq. ft. with manufacturing capacities confirming to

stringent TGA/MHRA approvals; possessing an installed capacities of 3 billion units comprising

tablets, capsules, Ointments, Injectable, Liquids & Dry Syrup (all latest formulations with a

marketing network.

API section has spread over an area of 7 Lac sq. ft, carried out at 3 different state-of-the-art units

approved by USFDA and E.U regulatory authorities with a marketing network spread over in 40

countries viz. Europe/USA/Middle East possessing 2 patented molecules with 11 molecules in

offing It possesses 50% exports percentage. Ind Swift entered into bulk drugs with its own

Research and Development facility and laboratories at Derabassi. Later on, those units got

USFDA approval and got the process patents for Clarithromycin for US and allied markets and

further five more patent drugs await clearance for the moment. A joint venture with Iran has also

been signed for the manufacturing of Clarithormycin with construction underway and will start

operations by the end 2008. The company has offices and supplies pharma drugs not only in

India but overseas as well.

R & D (Research & Development)

Ind Swift is known for it's reverse engineering ability with highly focused R & D capabilities

(duly approved by Department of Science & Technology, Govt. of India) and is equipped with

state-of-the-art equipment, facilities and talented pool of scientists and Researchers.

A well accepted expertise in NDDS, in India and the world over.

A US patent for Clarie OD, with a market size of US$ 300 million.

Another patent for Fexofenadine ODT with a market size of US$ 2.5 billion.

Development of 10 new molecules with a market size of US$ 6 billion.

Ind Swift's efforts and achievements in taste masking of macrolides was India's first......... and

remains the only feat of its kind in the country. The R &D department is also involved in

creating international opportunities and alliances for CRAMS business, contributing significantly

to the Company's profitability. It also offers complete support to international partners for

preparing and filing dossiers for finished dosages. By taking giant strides on roads less traveled,

Ind-Swift has become one of India's fastest growing pharmaceutical companies.

R & D's Achievement

Its pioneering R & D efforts have led to the creation and introduction of blockbuster drugs like:

Atrovastatin – One of the most effective cholesterol lowering drugs with an estimated market

size of US$ 12 billion.

Nitazoxanide – a wonder, one of its kind anti-diarrheal with a market of US$ 6 billion.

Pioglitazone – an anti-diabetic drug ranked among the first five in its Therapeutic segment.

Arthrill – an herbal wonder for the treatment of Arthritis.

Anaproct – an ayurvedic product providing relief from piles within 24 hours with no allopathic

cometitor.

Ind-Swift has strategic R&D and manufacturing alliances with companies in the United

Kingdom, Turkey and Iran.

In formulations front, Ind Swift proud of its multifarious achievements viz. Neurophen forte, a

composition of Ibuprofen & Acetamenofen. Ind Swift is the company to give this composition to

the country for the first time. Another formulation i.e. Suprox SR, a composition of Isoxprine

Hel, sustained release tablets was first time launched in India in tablet form. Mouth dissolving

tablets technology was introduced for the first time in India by Ind Swift. The company today

stands second in the north in pharmaceutical sector.

It is an honour to add here that we are among the top 500 fortune companies of India and have

been ranked at No. 35 by IMS/ORG in Pharmaceutical industry & possess a portfolio of 650

products with presence in high growth therapeutic segments of Cardiology, Diabetology, Anti

depressant, anti-allergic, Anti- infective, Neurology & Oncology with a nation wide distribution

network comprising 1200 marketing professional working with 12 marketing divisions, 50

offices in India, 3000 super stockists and stockists.

Sparkling footsteps on diversification front are as under mentioned:-

Infrastructures: Ind Swift has radianced up in infrastructures business in the name and style of

“Ind Swift Infrastructures and developers Ltd, and has come up with a multi crore project named

“Regalia Towers”, of course a society with 2 bedroom /3 bedroom flats and penthouses owing a

mystique which is exemplary in itself which not only reflects a diversified transformative spell to

infrastructures front but a unique state of art with the best of specifications also. In

infrastructures, Ind Swift plans to be emergent with motels & Resorts project in the upcoming

phases.

Publishing & Packagings:

Ind Swift by virtue of its strong business acumen has also put a step in the field of publications

also in the name and style of Mansa Print & Publishers Ltd's which has hovered over the industry

within a very short span by coming up with Aluminum Division in 2007 wherein the

manufacturing & printing of various type of packaging material viz. Aluminium collapsible

tubes, mono cartons etc is undertaken and now will add a new feather in ISL's cap by launching a

separate unit for PE, Lami tubes and PET bottles. Not only this it further proposes to come up

with a stationary unit for which the building has already been constructed. The total plan will

increase Mansa's sale by 200%.

Another project for Injunction moulding has also been proposed. Both these plants have a total

layout plan out of Rs. 40 crore.

Media & Publication :

Ind Swift has focused up in media & publication sector under the name “Ind Swift

Communications Pvt. Ltd” with its illustrious and infomercial journals as “Pharmabuzz”,

“Trendz”, ADI (Drug Index), Agrovet and further proposes to come up with General magazines

and tabloids.

Software Development:

Ind Swift has also entered into IT & software with their initial projects of developing web

portals, search engines optimizations, website development, software & ERP systems

development. Its initial portals which are already on air are OTC mart.com, buysweethome.com,

painting &photographs.com, doctorsonline.com & ayurvedaherbs.com.

Sparkling footsteps on diversification in Education front are under-

mentioned:-

Swift Institute:Our Swift Institute is exclusively diverse from the plenteous private educational

institutions cropping up in North India, having world class infrastructure, faculty, laboratories

and other facilities. To initiate with, we have instituted six months Industrial Training Courses in

Pharmaceutical Sciences, for Operator Level Training which has enabled the 10th or 10+2

students to start a career in the booming Pharma industry & until now we have already trained

and placed more than 400 students at Ind Swift which we feel contributes a lot to the skilled

manpower starving industry.

Swift Fundamental Research Education : SFRE (Swift Fundamental Research Education ) is a

society made under the banner of Ind Swift which has recently laid an another step on the

diversification spree and has forayed up with a Pharmacy college at Rajpura with the name &

style of “Swift School of Pharmacy”, and is a unique state of art with the best of specifications

also. With this new venture of IND SWIFT, we have been ranked as the pioneers in this part of

the country having a solid pharmaceutical industrial background to come up with our own

Pharmacy & Nursing institute. The institute will be operational from current session year 2008-

2009 with an intake of 60 students in the field of Pharmacy and Nursing each, in the first year by

virtue of its high resourcefulness and know-how and will provide quality education to one and

all, aspiring careers in the field of Pharmacy.

We manifest to be imminent with Engineering, Architecture, Management, Hotel Management,

General Management, Schools of Dentistry, Ayurveda Physiotherapy and Medical Technology

and finally a Medical College with its functioning operational by 2010-11 under the budget of

Rs. 250 Crore with a specific target on Medical Tourism.

Domestic Marketing: The company's new division “diagnosis” dealing in medical equipments

& devices thereby focusing personal health care was launched in December 2007 and has

reflected promising performance & is growing leaps and bounds from the first month of its

launch which has given utmost confidence to the company to get the aggrandized sales and

contribution not in the current year but in the forthcoming years as well. Not only this, the

division projects to achieve a business objective of 10 crores with impressive contribution to ISL

and possesses a strategy of adding up few other specialty products in the existing range of

personal health care & Academic Body model series.

Another division launched by your company is “Animal Health Care” which is an absolutely

new concept with outsourced marketing and has proved out to be an individual profit center.

Apart from struggling uphill for the current range of products our Ethical marketing have

introduced those products during the year which are monopolistic in nature viz. Cirrholiv which

has proved out to be a remedy in Hepatitis and other liver disorders. Other brands introduced by

your company during the year are Topclav 625, Emtee 25 and Timcol Eye Drops.

In Generics, your company emerged as the 2nd rank Pharma Generic company and has attained

the fame of featuring its few brands (Amyclox, Swimox, Oxo, Swiflox and Cafzone (already

achieving the sales growth over 25 crore) as the top brands in Generics. Company's brand

Swimox has been enlisted among leading brands in ORG IMS and Amyclox leads the que

among top 300 brands of the industry.

Annual growth for the company during the year is 36.73%.

RESEARCH & DEVELOPMENT

Looking at the current scenario where the pharmaceutical majors are engaged in the

advancement of R & D, we have been competent enough to work out on non infringing

processes, Novel Drug Delivery Systems, dossiers, stability data profiling, conceptualization of

new molecules (and therefore a nmber of product combination have been developed and are

ready to be launched by our marketing divisions). Your company's R&D is involved in creating

international opportunities and alliances for CRAMS (specially contract Research) to make it

contribute 30% of profits. Till date two major contracts were signed an have been delivered. We

are hopeful to attain more contracts on product development and stability data profiling. Apart

from this, we are applying invincible efforts to get approvals for a Bio-equivalence centre which

will further strengthen the basket of R&D. To strengthen the CRAMS business to the exquisite

level, your company is tying up with various academic institutes.

By virtue of the hard endeavors of R&D all through the year, unique combinations/NDDS of

single molecule are around the corner and awaiting launch by this year. Apart from this, R&D is

emphasizing on a major area which is cost Reduction. More than 5% of total revenues have been

planned to spend on the company's R&D and the same will be continued in the forthcoming

years as well.

Units of IndSwift: IndSwift has two units in PARWANOO and two in BADDI.

Mission:

Vision:

Ind Swift Ltd.

Moving towards INR - 1000Cr. by 2010

Values

1.Consistent Profitable Performance

2. Commitment to maximize the wealth of our shareholders and catering to the interests of our

customers and employees.

3. Innovation to Nurture Good Partnerships with Customers

4. Develop therapies and processes and provide services of the highest value to nurture good

partnerships with customers

5. Responsibility towards Environment, Safety and Health

6.Nurturing the undying spirit for researching active substances to combat disease, protect the

environments we inhabit, and the Society we serve.

7.Commitment to the Highest Standards of Ethics & Integrity

8.Actions in accordance with words and values. Respecting the laws in business ethics of the

countries in which we operate.

9.Valuing the Ability to Excel, Integrity, Knowledge, Skill, Diversity and Team work of

Employees

10.Treat everyone fairly and with respect to create an environment of Mutual respect,

encouragement and teamwork.

Future and history:

In today’s world of rapid change, future shock is no longer shocking. To those who do not plan

for future, future may come too soon. But to those with careful preparation and accurate

anticipation, to those with vision, future is where we are going to prosper. Towards which

desirable end, we endeavour today.

With promising molecules in our manufacturing pipeline, we are going to meet our future with

great preparation and nonchalance.

For details visit our group company’s website Indswift Labs Limited.

To develop various types of NDDS for selected therapeutic segments. 12 new drug / combination

being developed under NDDS to be introduced first time in India.

• Contract research

• Contract manufacturing

Joint ventures in marketing finished dosage forms in India, SAARC and South East Asian

countries.

- Dedicated to be an integrated healthcare company:

- Chain of Multi -specialty hospitals

- Pharmacy chain

- Chain of diagnostic laboratories

CHRONICLE:

2007-2008

Company has achieved the 35th rank among top 300 pharma industries in 2007-08

Company has got international approvals viz. MHRA(UK),TGA(Australia),WHO(Geneva) and

other such regularly bodies.

We achieved MoH(UAE),TFDA(Tanzania),NDA(Uganda) and DACA(Ethiopia).

The company's new division Diagnozis dealing in medical equipments and devices was launched

in December 2007.

Animal Health Care is another division launched by our company which is absolutely new

concept with outsourced marketing.

Ethical marketing Division of the company introduced products during the year viz. Cirrholiv

useful in curing Hepatities and other liver disorders.

In Generics,company merged as the 2nd rank Pharma Generic Company

New brands in Generic are Amyclox,Swimox,Oxo,Swiflox and Cafzone achieving the sales

growth over 25 crore.

Company's manufacturing unit at Parwanoo has also been upgraded as per WHO standards.

Company's Global Business unit (GBU) at Derabassi has got MHRA & TGA approval.

Manufacturing unit at Baddi(H.P.) received WHO GMP certification for tablet/SVP/Liquid

manufacturing.

2006-2007

Company has entered in an advanced stage of Launching its products in the International

Markets.

The Company's 100% Export Oriented Global Business Unit,(GBU) is complaint to the GMP

specifications of MHRA(UK),TGA(Australia) and other regulatory bodies.

Company also launched its product in Kenya and Senegal.

The Company has filled more than 100 dossiers for registration in about 20 countries around the

world stretching from South America to Philippines.

The third new division is Agile which has been launched in joint venture with a Dubai based

Pharma company focusing on Pain Management & Anti-infectives.

The Company introduced various new product ranges in the domestic markets through its 12

marketing divisions,a total of 40 offices in India,3000 stockists & superstockists across the

country with an enhanced field force of 1400 marketing professionals endeavoring hard in

broaden therapeutic segments of Cardiology,Diabetology,Neurology and Oncology.

Company has been ranked 41st among top 50 leading pharmaceutical giants.

Company R&D with available scientific pool of 100 scientists working on different projects on

dossiers,DMFS in CTD formats,stability data profile,conceptualization of new

molecules,planning for bioequivalence and clinicals.

More than 5% of total revenues have been planned to spend on the company's R&D .

Company's another feather in its cap is its new manufacturing facility for soft gelatin

encapsulation with an annual capacity of 35 Crore Soft gelatin Capsules, which will be put into

operation during current financial year.

2004-2005

Launched combination of Nitazoxanide and Ofloxacin, with the brand name Netazox-OF, first

time in Asia.

Ind Swift Group achieved a turnover of 480 crores.

2004

Launched Mukur Division with focus on ophthalmology, neuropsychiatry and ENT.

Another division launched by the name Resurgence catering to the Anesthesiology and Oncology

segments.

Ind-Swift group achieved a turnover of INR 375 Crores.

Launched Nitazoxanide, an antidiarrhoeal drug, first time in India after successful clinical trials.

Got DGQA registration

Opened first overseas office in New Jersey, USA

2003

Ind-Swift group achieved a turnover of INR 300 Crores

Launched another division by the name Ind-Swift Biosciences.

Ind-Swift enters into formulations export to 6 countries.

Filed Patent in US for Clarithromycin

2002

Bagged ISO 9001-2000 Certification.

Attained leading position in the world in the products like Clarithromycin granules

Exports to almost 40 countries in the world and set up eleven representative offices worldwide.

2001

Launch of Institution/Hospital Division.

2nd Company to launch Pioglitazone and Candesartan in India

2000

Launched Super Specialty Division (SSD) focusing on Cardiology and Diabetology segments.

1997

A 30 crore multipurpose plant commissioned with five independent blocks erected as per cGMP

and US FDA standards, designed by Quara, Switzerland.

Another Marketing Division launched with the name Ind-Swift Health Care.

1996

Ind-Swift floated Ind-Swift Laboratories Limited in 1995 to initiate a backward integration into

the manufacturing of APIs and advanced intermediates.

1994

Ind-Swift went public with issues oversubscribed 52 times

1991

Set up a manufacturing facility for injectables and eye/ear drops.

1986

Birth of Ind-Swift limited.

Introduced for the first time in India sustained release tablet of Isoxsuprine HCL

1983

Year of Foundation

MARKETING:

• 1000 professionals in different divisions market finished dosage forms throughout the

country.

• Over 40 offices in India

• Eleven representative Offices worldwide.

• Strong doctors base of over 2.5 lakh doctors of various specialties.

• Strong retailer coverage base of over 3 lakh retailers’.

• Stockists base of over 3000 all over India

MANUFACTURING:

• All the manufacturing units are designed to comply with current GMP norms as proposed

by stringest world regulatory bodies like USFDA, MHRA, EU, and WHO, and accreditations

from ISO 14000

• Ind-Swift is known as one of the biggest global bulk producers of APIs like

clarithromycin, fexofenadine, atorvastatin etc. (For details visit our group company’s website

Ind-Swift Labs Limited.)

• Launched combination of Nitazoxanide and Ofloxacin, with the brand name Netazox-OF,

first time in Asia

• Launched Nitazoxanide, an antidiarrhoeal drug, first time in India after successful clinical

trials

QUICK FINANCIAL SYNOPSIS:

BRIEF: For the fiscal year ended 31 March 2009, IND Swift Ltd's revenues increased 14% to

RS5.92B. Net income increased 1% to RS314.5M. Revenues reflect an increase in income from

operations. Net income was partially offset by an increase in consumption of raw materials,

higher purchase of traded goods, an increase in employee cost, higher depreciation &

amortisation expenses and lower other income.

Price Performance

Period Actual (%)

4 Week 4.90

13 Week 32.49

26 Week 61.64

52 Week -13.77

YTD 53.93

Price History

Period Value

12 Month High 26.80

12 Month Low 10.50

Current P/E 2.41

Balance sheet  Mar ' 08 Mar ' 07 Mar ' 06 Mar ' 05 Mar ' 04

Sources of funds

Owner's fund

Equity share capital 7.44 7.44 7.44 7.28 4.63

  Mar ' 08 Mar ' 07 Mar ' 06 Mar ' 05 Mar ' 04

Share application money 0.16 0.16 2.95 3.10 6.04

Preference share capital - - - - -

Reserves & surplus 170.62 141.17 119.34 102.52 65.74

Loan funds

Secured loans 308.91 227.50 153.09 90.36 49.63

Unsecured loans 83.00 74.80 40.58 27.08 18.02

Total 570.12 451.07 323.39 230.33 144.06

Uses of funds

Fixed assets

Gross block 159.34 96.99 50.80 32.23 23.90

Less : revaluation reserve - - - - -

Less : accumulated depreciation 18.12 12.07 8.28 6.20 4.88

Net block 141.22 84.92 42.52 26.03 19.02

Capital work-in-progress 97.49 98.75 88.85 22.88 4.70

Investments 28.30 18.76 15.39 18.67 14.75

Net current assets

Current assets, loans & advances 425.04 330.58 218.45 192.76 137.36

Less : current liabilities & provisions 147.18 106.94 60.33 41.22 37.54

Total net current assets 277.86 223.65 158.12 151.54 99.82

Miscellaneous expenses not written 25.25 24.99 18.51 11.22 5.76

Total 570.12 451.07 323.39 230.33 144.06

Notes:

Book value of unquoted investments 5.39 - 5.27 4.61 2.08

Market value of quoted investments - - 52.54 87.90 -

Contingent liabilities 19.38 - 43.87 54.50 83.42

Number of equity sharesoutstanding (Lacs) 371.78 371.78 371.78 72.76 46.25

Market Capitalisation

Market Cap (Rs Millions) 756.58

Shares Outstanding 37.18

Float 23.50

Per Share Data (Rs INR)

Earnings 8.45

Sales 159.26

Book Value --

Cash Flow --

Cash --

Valuation Ratios

Price/Earnings 2.41

Price/Sales 0.13

Price/Book --

Price/Cash Flow 1.86

Management Effectiveness (%)

Return on Equity --

Return on Assets --

Return on Investment --

Profitability Ratios (%)

Gross Margin 26.40

Operating Margin 6.68

Net Profit Margin 5.31

Dividend Information

Dividend Yield (%) --

Dividend Per Share (Rs INR) 0.0

Payout Ratio --

Financial Strength

Quick Ratio --

Current Ratio --

LT Debt/Equity --

Total Debt/Equity --

Chart for indswift(stock exchange)

PRODUCT RANGE AND LAUNCH:

Product Therapeutic Position at the time of launch in India Year ofLaunch

Netazox Anti diarrhea 1st 2004

Clarie OD Macrolide 2nd 2003

Glitter Anti diabetic 5th 2001

Candez Cadiovascular 2nd 2001

Atstat Cardiovascular 4th 2000

UT Guard Vasodilator 2nd 2000

Fexidine Anti histamine 3rd 2000

Excef Antibiotic 3rd 1999

Clarie DT Macrolide 1st 1999

Clarie Macrolide 2nd 1998

Suprox SR Vasodilator 2nd 1987

Anin Allyoestrenol 2nd 1985

Product Range of the Ethical Division of Ind - Swift

» INJ ANIN-250

» INJ ANIN-500

» INJ DECANEUROPHEN-25

» INJ DECANEUROPHEN-50

» INJ NEUROPHEN-25

» INJ UTGARD(5 ML)

» INJ. UTGARD (1 ML)

» INJ. VORANIN-100

» INJ. VORANIN-200

» INJ INORINE 2 ML

» TAB ANIN

» TAB CLARIE - 250

» TAB CLARIE - OD

» TAB CLARIE DT

» TAB COZY PLUS

» TAB ETOXIN - B

» TAB NEUROSPAS CD

» TAB SUPROX

» TAB SUPROX SR

» TAB STEMIN

» TAB STEMIN FORTE

» TAB. INDAXIN -B6

» TAB. INDCEF-DT

» TAB. INDCEF-100

» TAB. INDCEF-200

» TAB. UTGARD

» TAB GLUFIT-15

» TAB GLUFIT-30

» TAB.MENOGUARD

» TAB.NEUROSPAS-MF

» TAB TOPCLAV-625

» TOPCLAV D/SYRUP

» TAB TOPCLAV-375

» TAB INORINE

» TAB INORINE-M

» TAB TERPREG 200 MG

» TAB EMTEE

» TAB ERGEST - LD

» TAB ERGEST

» TAB FERTILIN-50

» TAB MEDANIN-10 MG

» TAB CALSTAT

» TAB CALSTAT-DS

» TAB OFREE

» CAP NEUROPHEN FORTE

» CAP NEUROSPAS

» CAP DISTONE

» CAP BENPROST-8

» CAP VORANIN-100

» CAP. VORANIN-200

» CAP MUBEXIN

» CAP. ANAPROCT

» CAP INDILAC

» CAP. CIRRHOLIV

» CAP CALSTAT-BD

» CAP PM CARE

» COZY KID

» ETOXIN-B EXPECTORANT

» PHENA KID

» PHENA P

» OLIADE BATH OIL

» COZY COOL DROPS

» NEUROSPAS-DROPS

» DISTONE SYRUP

» CALSTAT-SUSP

» UTININ SYP

» STEMIN-GM

» STEMIN-MF

» ANAPROCT OINTMENT

» MUBEXIN ZINC DROPS

» INDCEF-LB DRY SYRUP

» GDSAFE DRY SYRUP

» GDSAFE-DS DRY SYRUP

» SYP. AMBICET

» INDILAC SACHET

Ayurvedic products:

Proven Ayurvedic remedy for cardiovascular ailments Helps in maintaining optimal blood pressure Lowers blood cholestrol

Useful aid for liver ailments

Helps in controlling DIABETES Mellitus Helps maintaining appropriate Blood Sugar Level Important in Comprehensive Diabetic Care

Works as Anti Stress (Adaptogen) Works as Anti Oxidant Restores and enhances Physical & Mental Endurence

Useful in Respiratory system ailments

Improves quality of semen Improves Sperm Count and motility. Effective in Impotency Improves nourishment to body tissues Promotes urinary flow

Optimize Gastrointestinal Function Natural and gentle Laxative useful in constipation Effective in Heartburn and stomach upset Useful in Chronic Diarrhoea and Piles Combines well with Amalakiy

As Lipid Regulator, Alters Lipid Metabolism Promotes good cholestrol Lowers bad cholestrol Lowers triglyceride and Effective in maintaining healthy Cardiovascular system.

Excellent Blood Purifying properties Natural aid for Skin diseases Bitter taste helps in worm infestations and viral infection Effective in Diabetic care

Trusted Immune System Booster Possess immuno enhancing properties Helps in enhancing body's own defense mechanism Effective in all acute and chronic ailments Useful in general debility

Anti Aging : Shilajit has unmatched powers of arresting and reversing the aging process.

Counteracts free radicals and arrests degenerative disorders Maintains the Equilibrium of Energy Metabolism in our body. Helpful in allevating complication of blood sugar.

Most Trusted Liver Rejuvenator Possess Hepatoprotective properties Possess Liver Nourishing properties Useful in varieties of liver disorder

Helps improving Intellectual capability Enhances Mental Ability Enhances Learning abilities Improves Concentration and Memory

Effective Nervine tonic Useful in low sperm counts Useful in general debility Useful in diseases of old age related to Nervous system

Trusted Natural Anti Oxidant Richest natural source of Vitamin C (Ascorbic acid). Reduces free radicals and is helpful in degenerative disorders. Usefull for mainitaining lusture of skin and hair

Anti Stress (Adaptogen) Rejuvanates Body as well as Mind Useful in loss of Vigor and Vitality Helps in allevating Anxiety Usefull in loss of Sleep

Ensures Optimum Respiratory function Ensures Optimum Bronchial Effectiveness Liquifies Sputum Helps to cop with air pollution and allergens

Trusted Obessity Controller Helps maintaining an appropriate body mass index Helps you keep active throughout the day Helps in maintaining weight Inhibits the synthesis of fatty acids and lipids in body

Possess Diuretic and Anti Inflamatory Properties Supports and maintain optimum Gentiurinary Function Stimulates Diuresis Maintain normal urine output Effective in inflamatory and painful condition

Time Tested Aphrodisiac for female Helpful in failing Lactation Promotes urinary flow Reduces gut Motility

Stops fat deposition Reduce the absorbtion of starch calories All natural Non-stimulant

It helps in breaking down fats. Regulates the appetite It helps stabilize the Glucose -Insulin (GI) level It maintains ideal body weight by checking basal metabolic rate (BMR).

It is used in the treatment of excessive uterine bleeding and dysmenorrhoea.

It is popular herb for treating menstrual abnormalities and leucorrhea. It is used in the management of back pain associated with leucorrhoea. It is used as uterine tonic.

It is used in the treatment of excessive uterine bleeding and dysmenorrhoea.

It is used in the treatment of nervous system diseases. It is used in treating depressive illness and hysteria.

Garlic Lowers elevated Cholesterol Useful in digestive system ailments and heartburn. Useful in mild Hypertension. Garlic helpful in arthritis and rheumatism. Garlic as Antibacterial and Antifungal. Garlic as an Anti Oxidant.

Useful in alleviating symptoms associated with mild to moderate depression.

Has antiviral and anti-inflammatory properties It is useful in depression associated with menopausal symptoms It is devoid of ill effects and is safe for prolonged use

Useful in Erectile Dysfunction Herbal Sex Simulant, Improves Stamina Increases Sexual Desires, Enhances Sexual Pleasures. Natural Herbal Sex enhancer helps in Loss of Libido Strengthens the Nervous Tissues, revitalises Body & Mind Promotes quality and quantity of semen.

Board and directors and staff:

Mr. S. R. Mehta Chairman

Mr. N.R.Munjal Vice Chairman

Dr. G. Munjal Managing Director & CEO

Dr. V. R. Mehta Jt.Managing Director

Mr. Himanshu Jain Executive Director

Mr. V. K. Mehta Director

Mrs. Nirmal Agarwal Director

Mr. K.M.S.Nambiar Director

Dr. N.D.Aggarwal Director

Dr. R.S.Bedi Director

Dr. H.P.S.Chawla Director

Dr. S.K.Mathur Director

Mr. N.K.Bansal Group Head(Finance)

Mr. Amit Tarafder Vice President(Finance)

Mr. R.K.Sood Company Secretary

Mr. O.P.Thapliyal vice president (HR)

Mr. Gaurav Aggarwal vice president (commercial)

Mr.Anurag Kastwar vice president (marketing)

Mr.J.S. Saini senior manager( marketing)

CHAPTER- 3

OBJECTIVE OF THE STUDY:

1> To assess the usage of allopathic or ayurveda system by the doctors.

2> To study the preferences of the systems by the doctors taking the reasons

as side effects, time duration , safety.

3> To study the availability the medicines in clinic or nearby retailers .

4> To know diversifying allopathic to ayurveda by industries is right step or

not.

5> To study the order of preferences by the doctors towards the different

medical professionals.

SCOPE OF THE STUDY:

The scope of study means the subject matter to be researched in the study . it

defines the overall rationale of the study by explaining the geographically area of the study along

with type of the data. In order to accomplish the objectives of the project . survey conducted in

himachal Pradesh and Chandigarh to fill the questionnaire by the doctors which designed for the

purpose of the survey . on the basis of data collected I analysis the result of the project .

RESEARCH METHODOLOGY

In order to gets information by various reasons the research methodology is as follows:

DATA COLLECTION:

Adequate and authentic data is the foundation stone for an analysis. It is very necessary that the

data should be adequate and relevant so that the analysis which we derive from that data is exact.

So data collection requires due attention and care. In order to get the required basic information

about the usage of medical system by doctors and for what disease . I relied on both primary data

and secondary data.

PRIMARY DATA:

Regular visit to the organization i.e.IndSwift Ltd. In Chandigarh and after regular visit to market

and meetings with doctors was made to obtain the required information and learn about the

market and organisation how it works. Interviews with the management officials’ and staff of the

organization to get latest information.

SECONDARY DATA:

Books, Magazines, Articles from internet etc. constitute the secondary sources of information for

the project report.

SAMPLING PLAN:

Universe : The population of study consists of doctors and retailers (pharmacy shops) I

hamirpur and chandigarh.

Sample Size : Sample Sizes 40 respondants. 20 doctors of ayurveda and 20 from allopathic .

Sampling Technique : I have used technique of convenience sampling.

Geographical scope: hamirpur (h.p) and chandigarh . .

Tool for data analysis : Percentage method for getting results.

AN OUTCOME OF RESEARCH METHODOLOGY

Collection of Information from IndSwift.

Taking permission from guide.

Getting questionnaire filled from people

Analysis of information

Interpretation of data

Suggestion and Recommendations

CHAPTER-4

Evaluation study to assess the usage of Allopathic and ayurvedic system BY doctors (VIEWS OF AYURVEDA DOCTORS)

NAME: …………………………………… QUALIFICATION…………………………… DATE : .....................................

Q.NO: 1: DO YOU USE ALLOPATHIC PRODUCTS? a. YES b. NO

C. AT TIMES

Q.NO:2: NAME OF THE DISEASE FOR WHICH YOU PREFER ALLOPATHIC

TREATMENT

a. GIT

b. LIVER DISORDER

c. HEART DISEASE

d. CANCER e. ANY OTHER (PLEASE SPECIFY)………………………………. .

NO RESULT % 20

Q.NO:3: (A) DOES PATIENT OVERALL SATISFIED WITH ALLOPATHIC

PRESCRIPTION AND MEDICINE GIVEN BY YOU?

a. YES

b. NO (B) IF NO, WHAT IS THE COMPLIANCE OF PATIENT FOR ACCEPTANCE OF ALLOPATHIC TREATMENT ………………………………………………………………………………………………………………………………………….. .

NO RESULT % 20

Q.NO:4: YOUR PREFRENCE TO ALLOPATHY IS THEIR SHORT DURATION OF

TREATMENT AS COMPARE TO AYURVEDIC

a. STRONGLY AGREE

b. AGREE c. NEUTRAL

d. DISAGREE

e. STRONGLY DISAGREE

NO RESULT % 20

Q.NO:5: (A) WHETHER MEDICINES ARE GENERALLY AVAILABLE WITH NEAR BY RETAILERS a. YES b. NO

(B) IF NO, WHAT IS REASONS FOR NON PROVIDING MEDICINES TO PATIENTS ........................................................................................................................................

. NO RESULT % 20

Q.NO:6: DO YOU BELIEVE IN COMBINATION THERAPY (ALLOPATHY WITH AYURVEDA) ? a. YES

b.NO

c. AT TIMES

NO RESULT % 5

Q.NO:7: WHAT IS THE TIME DURATION YOU PREFER FOR ALLOPATHIC TREATMENT? a. 3 DAYS

b.3-5 DAYS

c. A WEEK

d.MORE THAN A WEEK

Q.NO:8: IN NEW ERA OF MEDICINE, COMPANIES ARE DIVERSIFYING FROM ALLOPATHIC PRODUCTS TO AYURVEDA. DO YOU THINK THIS IS THE RIGHT STEP? a. YES b. NO

PLEASE COMMENT ON YOUR ANSWER …………………………………………………………………………………………… .

Q.NO:9: DO THE PATIENT SHOWS THEIR PREFERENCE TO ALLOPATHIC SYSTEM a. YES

b. NO

Q.NO: 10: WHAT IS YOUR ORDER OF PREFERENCES IN RESPECT OF VARIOUS SYSTEMS OF MEDICINES LIKE HOMEOPATHIC , ALLOPATHIC , AYURVEDA , UNANI.

a. 1ST ………………………………………

b. 2ND ……………………………………..

c. 3RD ……………………………………….

d. 4TH ………………………………………85% GIVE 1ST RANK TO AUYURVEDA

15% GIVE 1ST RANK TO ALLOPATHIC

Evaluation study to assess the usage of Allopathic and ayurvedic system BY doctors (VIEWS OF ALLOPATHY DOCTORS)

NAME:…………………………………… QUALIFICATION:…………………………… DATE :.....................................

Q.NO: 1: DO YOU USE AYURVEDIC PRODUCTS? a.YES b.NO

c.AT TIMES

Q.NO:2: NAME OF THE DISEASE FOR WHICH YOU PREFER AYURVEDIC TREATMENT a. GIT

b.LIVER DISORDER

c.HEART DISEASE

d.CANCER

e.ANY OTHER (PLEASE SPECIFY)………………………………. .

Q.NO:3: (A) DOES PATIENT OVERALL SATISFIED WITH AYURVEDIC PRESCRIPTION AND MEDICINE GIVEN BY YOU?

a. YES

b. NO (B) IF NO, WHAT IS THE COMPLIANCE OF PATIENT FOR ACCEPTANCE OF AYURVEDIC ………………………………………………………………………………………………………………………………………….. .

Q.NO:4: THE REASONS FOR PREFERENCE OF AYURVEDIC MEDICINE, IS THEIR SAFETY AND NO SIDE EFFECTS . a. STRONGLY AGREEE

b.AGREE

c.NEUTRAL

d.DISAGREE

e. STRONGLY DISAGREE

Q.NO:5: (A) WHETHER MEDICINES ARE GENERALLY AVAILABLE WITH NEAR BY RETAILERS a. YES

b. NO (B) IF NO, WHAT IS REASONS FOR NON PROVIDING MEDICINES TO PATIENTS ………………………………………………………………………………………………………………………………

.

Q.NO:6: DO YOU BELIEVE IN COMBINATION THERAPY (ALLOPATHY WITH AYURVEDA) ? a. YES

b.NO

c.AT TIMES

Q.NO:7: WHAT IS THE TIME DURATION YOU PREFER FOR AYURVEDIC TREATMENT? a. A WEEK

b.A MONTH

c.SIX MONTHS

d. MORE THAN SIX MONTHS

Q.NO:8: IN NEW ERA OF MEDICINE, COMPANIES ARE DIVERSIFYING FROM ALLOPATHIC PRODUCTS TO AYURVEDA. DO YOU THINK THIS IS THE RIGHT STEP? a. YES

b. NOPLEASE COMMENT ON YOUR ANSWER ……………………………………………………………………………………………

Q.NO:9: DO THE PATIENT SHOWS THEIR PREFERENCE TO AYURVEDIC SYSTEM? a. YES

b. NO

Q.NO: 10: WHT IS YOUR ORDER OF PREFERENCES IN RESPECT OF VARIOUS SYSTEMS OF MEDICINES LIKE HOMEOPATHIC , ALLOPATHIC , AYURVEDA , UNANI. a. 1ST ………………………………………

b.2ND ……………………………………..

c.3RD ……………………………………….

d. 4TH ………………………………………

90% says allopathic

10% says ayurveda.

CHAPTER-5

SUMMARY

This study is based on the usage of two medical system by the different doctors . in this whole

project the result was carried out by fillong the questionnaire from the doctors of allopathic and

ayurvedic system. This study helps in to find out that which system is still suitable for the

chronic disease. Through this customer preference toward which system has been studied. This

study also shows the doctors preferences towards the combination therapy and market research

from which , get the views of doctors on the diversifying system from allopathic to ayurveda.

Questionnaire is totally based on straight answer from which we get the result fast and it become

easy to find the appropriate views of doctors on the subject of study. The analysis leads to

conclusion.

CONCLUSION

In my market survey I found weightage towards the allopathic products . 35% of allopathy

doctors use ayurveda medicine in prescription but in case of ayurvedic doctors 80% of them ,

they are using allopathic medicine in prescription. I also find that the combination therapy made

by doctors doing great job in healing the disease like coronary heart disease , cancer and many

more chronicle diseases. As allopathic is first preference by the doctors but ayurveda is

upcoming one. Allopathy and ayurveda are as different as day and night, and hence the two sets

of opposing views. However, if one has to compare ayurveda and allopathy on one platform,

then such comparison might be a tad difficult. "Allopathy treats individuals as an independent

physical entity like a machine. It is further sub-divided into various organs and systems looked

after by different specialties. Whereas, ayurveda treats the individual as a whole, considering

him to be a part of the universal whole. A positive aspect in the whole ayurveda vs allopathy

issue, is the fact that, people are now open to know more about this ancient science. Also while

there might not be prejudices or bias against the same, there are certain misconceptions, which

can only be dispelled with knowledge and information dissemination. "There are no prejudices

surrounding ayurveda. There may be misconceptions regarding its practice. If anything, the

interest in this system of medicine has been growing rapidly both in the domestic and

international market, attesting to its popularity and widespread acceptance .

RECOMMENDATION:

According to findings that in current scenario doctors and patient move towards the ayurveda but

allopathic still rules. I would like to recommend IndSwift

1. Doctors have yet to find a solution for conditions like cancer pain and chronic

pancreatitis in complementary therapies where modern interventional pain procedures are

very effective. So herbal drugs use in cancer and heart disease is going to be popular for

the doctors. This finding helps IndSwift to capture market by manufacturing of anti

cancer herbal drug.

2. My findings helps IndSwift that it should work on herbal medicines but along with

allopathic.

3. In future company get benefit if they prepare combination therapy medicines with no

side effect and try to be 100% cure guarantee.

QUESTIONNAIRE:

QUESTIONNAIRES ARE ATTACHED WITH THIS FILE NAMED ASQUESTIONNAIRE 01QUESTIONNAIRE 02

BIBLIOGRAPHY: Amare G, Gedif T, Alemayehu T, Tesfahun B. Pattern of drug use in Addis Ababa

community. East Afr Med J 1997;74(6):362-7.

Adjei DO, Arhinful DK. Effect of training on the clinical management of malaria by

medical assistants in Ghana. Soc Sci Med 1996;42(8):1169-76.

Brians Klaas and Thomas W. Gainey (1999).study of Determinants of disciplinary

system effectiveness. Journal of Economy and Society (1999).

D.R. Cooper and P.S.Schindler, Business Research Methods 9, (2006), pp. 505

Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA et al. Long

term trends in the use of complementary and alternative medical therapies in the United

States. Ann Int Med 2001;250(3):262-8.

Mitzdorf U, Beck K, Horton-Hausknecht J, Weidenhammer W, Kindermann A, Takaes

M et al. Why do patients seek treatment in hospitals of complementary medicine. J Altern

Complement Med 1999;5(5):463-73.

Nilsson M, Trehn G, Asplund K. Use of complementary and alternative medicine

remedies in Sweden. A population-based longitudinal study within the northern Sweden

MONICA project. J Int Med 2001;250(3):225-33

Wexler-Morrison NE. Plural medicine in Srilanka:Do Ayurvedic and Allopathic practice

differs? Soc Sci Med 1988;27:531-44

WEBSITES:

http://www.extensor.co.uk/articles/medicalsystem.html

http://www.allbusiness.com

http://www.extensor.co.uk/article_archive.php

http://www.managementparadise.com

http://www.google.co.in

http://www.indswift.com

http://www.researharticles.com/articlesmedicalveiws.html